ConvaTec Group Plc (OTCMKTS:CNVVY) Given Consensus Rating of “Hold” by Brokerages

Shares of ConvaTec Group Plc (OTCMKTS:CNVVYGet Rating) have been assigned an average recommendation of “Hold” from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $248.67.

CNVVY has been the subject of a number of recent research reports. JPMorgan Chase & Co. cut their target price on ConvaTec Group from GBX 278 ($3.47) to GBX 256 ($3.20) and set an “overweight” rating for the company in a research note on Friday, January 21st. Berenberg Bank began coverage on shares of ConvaTec Group in a research note on Thursday, March 17th. They issued a “buy” rating for the company. Credit Suisse Group decreased their target price on shares of ConvaTec Group from GBX 210 ($2.62) to GBX 195 ($2.44) in a research report on Friday, March 11th. Finally, Barclays increased their price target on shares of ConvaTec Group from GBX 290 ($3.62) to GBX 295 ($3.69) in a research report on Tuesday, March 1st.

ConvaTec Group stock opened at $10.43 on Friday. The business has a 50 day moving average price of $10.76 and a two-hundred day moving average price of $10.50. ConvaTec Group has a 12 month low of $9.06 and a 12 month high of $14.71.

The company also recently announced a dividend, which will be paid on Friday, June 3rd. Stockholders of record on Friday, April 1st will be issued a $0.1325 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, March 31st.

About ConvaTec Group (Get Rating)

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Featured Stories

Analyst Recommendations for ConvaTec Group (OTCMKTS:CNVVY)

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.